Oleanolic acid modulates multiple intracellular targets to inhibit colorectal cancer growth

Area of Science:

• Natural Product Chemistry
• Cancer Biology
• Molecular Pharmacology

Background:

• Current cancer chemotherapies face challenges due to drug resistance and severe side effects.
• Naturally occurring compounds are increasingly explored for their therapeutic potential in cancer treatment.
• Oleanolic acid (OA), a pentacyclic triterpenoid from medicinal herbs, has a history of use in treating human malignancies.

Purpose of the Study:

• To evaluate the efficacy of Oleanolic acid (OA) in inhibiting colorectal cancer (CRC) growth both in vitro and in vivo.
• To elucidate the molecular mechanisms underlying OA's anticancer effects in CRC.

Main Methods:

• Utilized a colorectal cancer (CRC) mouse xenograft model and the HT-29 cell line for in vivo and in vitro studies.
• Assessed tumor growth inhibition by measuring volume and weight.
• Investigated molecular changes including apoptosis, cell proliferation, protein expression (Bcl-2, Bax, Cyclin D1, p21, CDK4), and signaling pathway activation (Akt, p70S6K, MAPK, p53).

Main Results:

• Oleanolic acid (OA) significantly reduced tumor volume and weight in CRC xenograft mice.
• OA treatment induced apoptosis and inhibited cell proliferation in CRC cells.
• OA modulated key molecular targets: decreased Bcl-2, Cyclin D1, CDK4; increased Bax, p21; suppressed Akt, p70S6K, MAPK signaling; and activated the p53 pathway.

Conclusions:

• Oleanolic acid (OA) demonstrates significant anticancer activity against colorectal cancer.
• OA exerts its effects through the induction of apoptosis, inhibition of proliferation, and modulation of multiple intracellular signaling pathways.
• OA represents a promising natural compound for further development as an anticancer therapeutic agent.